Stories about Rhythm

Subscribe to Rhythm

02.11.2020 – 16:32

Aston Martin Lagonda of Europe GmbH

8
Aston Martin and Sir David Adjaye unite to create five luxury homes in New York City luxury high-rise tower, 130 William

Aston Martin Media Website
One document
more
08.10.2020 – 09:20

INTERSOUND

2
INTERSOUND releases tribute to ex-Beatle Norman Candler reinterprets John Lennon

more
06.07.2020 – 13:52

Technische Universität München
Gut bacteria improve type 2 diabetes risk prediction

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36118/ Images for journalists: https://mediatum.ub.tum.de/1552269 NEWS RELEASE Large-scale study with more than 4000 participants at ZIEL - Institute for Food & Health Gut bacteria improve type 2 diabetes risk ...

more
02.12.2019 – 09:50

Hannover Marketing und Tourismus GmbH

Winter needs anticipation: 8 Christmas season tips for the Hannover region

more
20.11.2019 – 05:02

Aston Martin Lagonda of Europe GmbH
Daisy Zhou encapsulates the Aston Martin DBX's spirit of adventure

Daisy Zhou encapsulates the Aston Martin DBX's spirit of adventure - The award-winning filmmaker has created a dynamic showcase for the new Aston Martin DBX - Light, emotion, colour and form come together with Aston Martin's first ever SUV as the star 20 November ...
Aston Martin Pressroom
One document
more
12.10.2019 – 10:45

Daiichi Sankyo
European Results From Global ETNA-AF Registry Show Low Bleeding and Low Cardiovascular Event Rates in Elderly NVAF Patients on LIXIANA® (edoxaban)

Munich (ots/PRNewswire) - - One-year outcomes of real-world edoxaban-treated European patients from the Global ETNA-AF registry showed low rates of potentially life-threatening bleeding and low CV events in elderly NVAF patients1 - The Global ETNA-AF programme is currently the largest and most comprehensive ...

more
04.09.2019 – 08:01

Daiichi Sankyo Europe GmbH
Daiichi Sankyo Presents Positive Results of the ENTRUST-AF PCI Study of LIXIANA® (edoxaban) in Patients with Atrial Fibrillation

Munich (ots/PRNewswire) - - ENTRUST-AF PCI study achieved the primary safety endpoint of non-inferiority in bleeding for edoxaban-based dual therapy compared with VKA-based triple antithrombotic therapy (using a risk-based duration of ASA for at least one month) in AF patients following stent placement - Data ...

more
22.08.2019 – 09:00

Daiichi Sankyo
Daiichi Sankyo Announces the Presentation of New Data on LIXIANA® (edoxaban) to be Presented at ESC Congress 2019

Munich (ots/PRNewswire) - - Data presentations from ENTRUST-AF PCI and ETNA-AF add to the growing body of scientific evidence from the Edoxaban Clinical Research Programme - First-time presentation of ENTRUST-AF PCI clincial results assessing edoxaban in atrial fibrillation (AF) patients following a successful ...

more
24.07.2019 – 10:48

Technische Universität München
Atrial fibrillation: New marker for atrial damage discovered

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 23325 - email: presse@tum.de - web: www.tum.de This text on the web: http://www.tum.de/nc/en/about-tum/news/press-releases/details/35595/ High resolution image: https://mediatum.ub.tum.de/1515114 NEWS RELEASE New marker for atrial damage discovered Protein in blood provides better control of treatment for atrial fibrillation Atrial ...

more
17.04.2019 – 09:56

Brose Fahrzeugteile SE & Co. KG, Coburg

3
Press Release: Auto Shanghai 2019: "Systems for Future Mobility" by Brose Enable New Driving Experiences

more
19.03.2019 – 10:30

Daiichi Sankyo Europe GmbH
Data from the Non-interventional EMIT-AF/VTE Study Shows Low Thromboembolic and Bleeding Event Rates in Unselected Elderly AF/VTE Patients on Oral, Once-daily LIXIANA® Undergoing Diagnostic or Therapeutic Procedures

Munich (ots/PRNewswire) - - In 2019, the Edoxaban Clinical Research Programme will deliver new evidence on LIXIANA® (edoxaban) use in clinical practice. EMIT-AF/VTE is one of the first sets of data to be presented - EMIT-AF/VTE is a large observational, multicentre, multinational study on edoxaban peri-procedural ...

more
18.03.2019 – 15:00

Daiichi Sankyo Europe GmbH
Daiichi Sankyo Presents Positive Results of the First Randomised, Controlled Trial of Uninterrupted Oral, Once-daily LIXIANA® (edoxaban) in Atrial Fibrillation Patients Undergoing Catheter Ablation

Munich (ots/PRNewswire) - - ELIMINATE-AF is the first set of data presented in 2019 from the Edoxaban Clinical Research Programme, which will deliver new evidence to support the use of edoxaban in clinical practice - Late-breaking data presented at EHRA 2019, the annual congress of the European Heart Rhythm ...

more
09.11.2018 – 13:59

Jacobs University Bremen

2
Experience the diversity of dance at Jacobs University

more

1